EUVIMEDEUVIMED entdecken
Open Access

PRDM16 Drives Thyroid Cancer Differentiation via a TRIM58-MVP Axis to Suppress MAPK and PI3K/AKT Signaling

Jialong Yu, Wei Luo, Zijie Niu, Miao Zhang, Yunqi Gao, Mengran Tian, Zhongyu Wang, Xing Wan, Han Gui, Qian Su, Wenhao Chen, Linfei Hu und 4 weitere

International Journal of Biological Sciences · 23.04.2026 · 22 (9) · 4747-4764

DOI: 10.7150/ijbs.131151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 23.04.2026. Verfasst von Jialong Yu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, Tianjin's Clinical Research Center for Cancer, Tianji…. Hauptthemen laut MEDLINE: Histone Methyltransferases, Major Vault Protein, MAP Kinase Signaling System, Thyroid Carcinoma, Anaplastic. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone MethyltransferasesMajor Vault ProteinMAP Kinase Signaling SystemThyroid Carcinoma, AnaplasticThyroid NeoplasmsAnimalsFemaleMiceCell Transformation, NeoplasticMice, Inbred BALB CMice, NudePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktThyroid GlandCell Line, TumorHumansTripartite Motif ProteinsDNA-Binding ProteinsTranscription Factors

Stichwörter der Autor:innen

MVPPRDM16TRIM58differentiationthyroid cancer

Substanzen

Histone MethyltransferasesMajor Vault ProteinMVP protein, humanPhosphatidylinositol 3-KinasesPRDM16 protein, humanProto-Oncogene Proteins c-aktTRIM58 protein, humanTripartite Motif ProteinsDNA-Binding ProteinsTranscription Factors

Autor:innen und Institutionen

  • Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • School of Medicine, Nankai University, Tianjin, China.
  • Department of Thyroid and Breast Surgery, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, China.
  • State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Key Laboratory of Radiopharmacokinetics for Innovative Drugs, Tianjin Institut…
  • Department of Molecular Imaging and Nuclear Medicine, Tianjin Medical University Cancer Institute and Hospital, Tianjin's Clinical Research Center for Cancer, Tianjin, China.

Zitieren

APA

Yu, J., Luo, W., Niu, Z., Zhang, M., Gao, Y., Tian, M., Wang, Z., Wan, X., Gui, H., Su, Q., Chen, W., Hu, L., Hou, X., Dong, Q., Ruan, X., & Zheng, X. (2026). PRDM16 Drives Thyroid Cancer Differentiation via a TRIM58-MVP Axis to Suppress MAPK and PI3K/AKT Signaling. International Journal of Biological Sciences, 22(9), 4747-4764. https://doi.org/10.7150/ijbs.131151

Vancouver

Yu J, Luo W, Niu Z, Zhang M, Gao Y, Tian M, et al. PRDM16 Drives Thyroid Cancer Differentiation via a TRIM58-MVP Axis to Suppress MAPK and PI3K/AKT Signaling. International Journal of Biological Sciences. 2026;22(9):4747-4764. doi:10.7150/ijbs.131151

BibTeX
@article{Yu2026,
  author = {Yu, Jialong and Luo, Wei and Niu, Zijie and Zhang, Miao and Gao, Yunqi and Tian, Mengran and Wang, Zhongyu and Wan, Xing and Gui, Han and Su, Qian and Chen, Wenhao and Hu, Linfei and Hou, Xiukun and Dong, Qiman and Ruan, Xianhui and Zheng, Xiangqian},
  title = {PRDM16 Drives Thyroid Cancer Differentiation via a TRIM58-MVP Axis to Suppress MAPK and PI3K/AKT Signaling},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  volume = {22},
  number = {9},
  pages = {4747--4764},
  doi = {10.7150/ijbs.131151}
}
Kostenlos starten →